Poor neutralizing antibody responses against SARS‐CoV‐2 Omicron BQ.1.1 and XBB in Norway in October 2022

New immune evasive variants of SARS‐CoV‐2 continue to emerge, potentially causing new waves of covid‐19 disease. Here, we evaluate levels of neutralizing antibodies against isolates of Omicron variants, including BQ.1.1 and XBB, in sera harvested 3–4 weeks after vaccination or breakthrough infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Vikse, Elisabeth Lea, Fossum, Even, Erdal, Magnhild Sekse, Hungnes, Olav, Bragstad, Karoline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236499/
https://www.ncbi.nlm.nih.gov/pubmed/37273461
http://dx.doi.org/10.1111/irv.13144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236499/
https://www.ncbi.nlm.nih.gov/pubmed/37273461
http://dx.doi.org/10.1111/irv.13144

Ejemplares similares